Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
25
Number of overlapping holdings
21.2%
% of XBI's 119 holdings also in IDNA
54.3%
% of IDNA's 51 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
INCYTE CORP | 2.4% | 4.0% | 2.4% |
|
REGENERON PHARMACEUTICALS | 2.3% | 3.7% | 2.3% |
|
EXELIXIS INC | 2.1% | 5.2% | 2.1% |
|
MODERNA, INC. | 2.0% | 2.9% | 2.0% |
|
REVOLUTION MEDICINES, INC. | 1.5% | 4.0% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IDNA
|
NATERA INC | 2.8% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
|
INSMED INC | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.7% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.6% |
|
GILEAD SCIENCES INC | 2.5% |
|
EXACT SCIENCES CORP | 2.5% |
|
AMGEN INC | 2.5% |
|
BIOGEN IDEC INC | 2.3% |
XBI Underweight Relative to IDNA
 |
BEIGENE, LTD. | -5.8% |
 |
ROCHE HOLDING LTD | -5.5% |
 |
SANOFI-AVENTIS | -5.5% |
 |
GSK PLC | -5.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -5.2% |
|
ASTRAZENECA PLC | -5.1% |
 |
GENMAB A/S | -4.6% |
 |
BIONTECH SE SPONSORED ADR | -4.2% |
|
MERCK & CO. INC. | -3.9% |
|
SPRINGWORKS THERAPEUTICS, INC. | -3.2% |